Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3308644 | Gastrointestinal Endoscopy | 2006 | 7 Pages |
Abstract
Telomerase activity can be measured readily in specimens obtained at EUS-FNA and accurately predicts malignancy. Used in combination with cytology, telomerase increased the sensitivity from 85% to 98% while maintaining the specificity at 100%. Lesions with negative cytology result and positive telomerase activity should be evaluated aggressively to exclude malignancy.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Girish MD, MS, Yiwen BS, John MD, Benoit C. MD, MSc(Epid), Doug PhD, Coty MD, A. William MD, Kim MD, Russell MD, Edward MD, Perry MD, Jamal MD, PhD,